Polymorphonuclear leukocytes (PMNLs) from uremic patients have elevated bas
al levels of cytosolic calcium ([Ca2+]i), reduced calcium signal after acti
vation of Fc gamma RIII receptor, and impaired phagocytosis. Chronic excess
of parathyroid hormone (PTH) in uremia mediates its effect on PMNL's metab
olism and function through the sustained elevation of their [Ca2+]i. Becaus
e calcium channel blockers interfere with this effect of PTH on PMNLs, trea
tment of patients on hemodialysis with verapamil, nifedipine, or amlodipine
was associated with an improvement in metabolism and phagocytosis of FMNLs
in humans. The therapy with calcium channel blockers should be continued i
n order to maintain its beneficial effects.